• IPO & Listed Companies
  • Funds and Managers
  • Private Companies
.
.
.
09/03/2024
  • Interviews

Season 2, Episode 3: Matthew Mills, CEO at Med-X, Inc.

 

On today’s episode of IR Update, Amanda Munhoz interviews Matthew Mills, CEO of Med-X. Matthew discusses Med-X’s founding, the importance of green solutions, and the company’s successful journey in pest control. He also details how the journey of crowdfunding for a direct NASDAQ listing is a strategic move to attract investment and expand operations.

Matthew also shares a personal story highlighting the dangers of traditional pest control methods and the development of natural products to initially deter rattlesnakes, realizing they address a much broader spectrum of pests. He details the company’s expansion plans and commitment to making a difference beyond pest control with a focus on wellness, with the launch of essential oil-based products for pest control and pain relief.

To fund all those initiatives, Med-X recently engaged with Maxim Group for a direct listing and crowdfunding strategy. This partnership for a NASDAQ listing is a strategic move to attract investment and expand operations, indicating strong future potential for Med-X.

Follow the MZ Insights page to learn more about direct listing, IPOs, and investor relations. We publish articles, studies, and interviews with IROs from all industries and regions.